MatigMavissakalianMD

PubMed

• 1 citations
  Rare copy number variation in posttraumatic stress disorder.
  Maihofer, A., Engchuan, W., Huguet, G., Klein, M., MacDonald, J., Shanta, O., Thiruvahindrapuram, B., Jean-Louis, M., Saci, Z., Jacquemont, S., Scherer, S., Ketema, E....> ;Molecular Psychiatry. 2022 Dec 1
• 19 citations
  Enhancing discovery of genetic variants for PTSD through integration of quantitative phenotypes and trauma exposure information
  Adam X. Maihofer, Karmel W. Choi, Jonathan R. I. Coleman, Nikolaos P. Daskalakis, Christy A. Denckla, Elizabeth Ketema, Rajendra A. Morey, Renato Polimanti, Andrew Rat...> ;Biological Psychiatry. 2021 Sep 1
• 7 citations
  Examining Individual and Synergistic Contributions of PTSD and Genetics to Blood Pressure: A Trans-Ethnic Meta-Analysis
  Jennifer A. Sumner, Adam X. Maihofer, Vasiliki Michopoulos, Alex O. Rothbaum, Lynn M Almli, Ole A. Andreassen, Allison E. Ashley-Koch, Dewleen G. Baker, Jean C. Beckha...> ;Frontiers in Neuroscience. 2021 Jun 23
• 42 citations
  Genomic influences on self-reported childhood maltreatment
  Shareefa Dalvie, Adam X. Maihofer, Jonathan R. I. Coleman, Bekh Bradley, Gerome Breen, Leslie A. Brick, Chia-Yen Chen, Karmel W. Choi, Laramie E. Duncan, Guia Guffanti...> ;Translational Psychiatry. 2020 Jan 27
• 276 citations
  International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci
  Caroline M. Nievergelt, Adam X. Maihofer, Torsten Klengel, Elizabeth G. Atkinson, Chia-Yen Chen, Karmel W. Choi, Jonathan R. I. Coleman, Shareefa Dalvie, Laramie E. Du...> ;Nature Communications. 2019 Oct 8
• 65 citations
  Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD
  Lori A. Zoellner, Peter P. Roy-Byrne, Matig Mavissakalian, Norah C. Feeny> ;The American Journal of Psychiatry. 2019 Apr 1
• 8 citations
  High expectancy and early response produce optimal effects in sertraline treatment for post-traumatic stress disorder.
  Belinda Graham, Natalia M. Garcia, Mark S. Burton, Andrew A. Cooper, Peter Roy-Byrne, Matig R. Mavissakalian, Norah C. Feeny, Lori A. Zoellner> ;The British Journal of Psychiatry. 2018 Oct 25
• 27 citations
  Do changes in trauma-related beliefs predict PTSD symptom improvement in prolonged exposure and sertraline?
  Andrew A. Cooper, Lori A. Zoellner, Peter Roy-Byrne, Matig R. Mavissakalian, Norah C. Feeny> ;Journal of Consulting and Clinical Psychology. 2017 May 15
• 53 citations
  WHAT WOULD YOU CHOOSE? SERTRALINE OR PROLONGED EXPOSURE IN COMMUNITY AND PTSD TREATMENT SEEKING WOMEN
  Norah C. Feeny, Lori A. Zoellner, Matig R. Mavissakalian, Peter Roy-Byrne> ;Depression and Anxiety. 2009 Aug 1
• 1 citations
  Switching from imipramine to sertraline in panic disorder.
  Matig R. Mavissakalian> ;Journal of Psychiatric Practice. 2004 Mar 1
• 4 citations
  Sertraline in panic disorder: Initial treatment versus switch strategy
  Matig R. Mavissakalian> ;Journal of Clinical Psychopharmacology. 2003 Dec 1
• 11 citations
  Imiprmaine vs. Sertraline in Panic Disorder: 24-Week Treatment Completers
  Matig R. Mavissakalian> ;Annals of Clinical Psychiatry. 2003 Sep 1
• 29 citations
  Duration of imipramine therapy and relapse in panic disorder with agoraphobia
  Matig R. Mavissakalian, James M. Perel> ;Journal of Clinical Psychopharmacology. 2002 Jun 1
• 14 citations
  Specific side effects of long-term imipramine management of panic disorder.
  Matig R. Mavissakalian, James M. Perel, Shenyang Guo> ;Journal of Clinical Psychopharmacology. 2002 Apr 1
• 7 citations
  Predictors of entering a long-term drug treatment study of panic disorder.
  Matig R. Mavissakalian, Shenyang Guo> ;Comprehensive Psychiatry. 2002 Mar 1
• 13 citations
  2nd Year Maintenance and Discontinuation of Imipramine in Panic Disorder With Agoraphobia
  Matig R. Mavissakalian, James M. Perel> ;Annals of Clinical Psychiatry. 2001 Jun 1
• 13 citations
  The side effects burden of extended imipramine treatment of panic disorder.
  Matig R. Mavissakalian, James M. Perel> ;Journal of Clinical Psychopharmacology. 2000 Oct 1
• 6 citations
  Cost Effectiveness of Acute Imipramine Therapy versus Two Imipramine Maintenance Treatment Regimens for Panic Disorder
  Matig R. Mavissakalian, Jordana K. Schmier, Jennifer A. Flynn, Dennis A. Revicki> ;Pharmacoeconomics. 2000 Oct 1
• 4 citations
  Generalized anxiety disorder versus panic disorder: participation in controlled efficacy trials.
  Matig R. Mavissakalian, Nadim Zamar> ;Comprehensive Psychiatry. 2000 Jul 1
• 30 citations
  Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
  Matig R. Mavissakalian, James M. Perel> ;Archives of General Psychiatry. 1999 Sep 1
• 4 citations
  Rational treatment of panic disorder with antidepressants.
  Matig R. Mavissakalian, Martin T. Ryan> ;Annals of Clinical Psychiatry. 1998 Dec 1
• 6 citations
  Life events and panic disorder/agoraphobia: A comparison at two time periods
  Ghada N Lteif, Matig Mavissakalian> ;Comprehensive Psychiatry. 1996 Jul 1
• 10 citations
  Phenomenology of panic attacks: responsiveness of individual symptoms to imipramine.
  Matig Mavissakalian> ;Journal of Clinical Psychopharmacology. 1996 Jun 1
• 5 citations
  The relationship of plasma imipramine and N-desmethylimipramine to response in panic disorder.
  Matig Mavissakalian, James M. Perel> ;Psychopharmacology Bulletin. 1996 Jan 1
• 33 citations
  Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
  Matig Mavissakalian, James M. Perel> ;The American Journal of Psychiatry. 1995 May 1
• Join now to see all

Journal Articles

• American Psychiatric Association Publishing  
  Matig Mavissakalian, Norah C Feeny, National Institutes of Health